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Abstract
Calcification-related chronic inflammatory diseases are multifactorial pathological pro-
cesses, involving a complex interplay between inflammation and calcification events in a
positive feed-back loop driving disease progression. Gla-rich protein (GRP) is a vitamin K
dependent protein (VKDP) shown to function as a calcification inhibitor in cardiovascular
and articular tissues, and proposed as an anti-inflammatory agent in chondrocytes and
synoviocytes, acting as a new crosstalk factor between these two interconnected events in
osteoarthritis. However, a possible function of GRP in the immune system has never been
studied. Here we focused our investigation in the involvement of GRP in the cell inflamma-
tory response mechanisms, using a combination of freshly isolated human leucocytes and
undifferentiated/differentiated THP-1 cell line. Our results demonstrate that VKDPs such as
GRP and matrix gla protein (MGP) are synthesized and γ-carboxylated in the majority of
human immune system cells either involved in innate or adaptive immune responses. Stimu-
lation of THP-1 monocytes/macrophages with LPS or hydroxyapatite (HA) up-regulated
GRP expression, and treatments with GRP or GRP-coated basic calcium phosphate crys-
tals resulted in the down-regulation of mediators of inflammation and inflammatory cyto-
kines, independently of the protein γ-carboxylation status. Moreover, overexpression of
GRP in THP-1 cells rescued the inflammation induced by LPS and HA, by down-regulation
of the proinflammatory cytokines TNFα, IL-1β and NFkB. Interestingly, GRP was detected
at protein and mRNA levels in extracellular vesicles released by macrophages, which may
act as vehicles for extracellular trafficking and release. Our data indicate GRP as an endog-
enous mediator of inflammatory responses acting as an anti-inflammatory agent in mono-
cytes/macrophages. We propose that in a context of chronic inflammation and calcification-
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Introduction
Inflammation and calcification are common events in chronic inflammatory diseases, such as
atherosclerosis and osteoarthritis, involving infiltration of monocytes and accumulation of
macrophages [1–5]. The interplay between inflammatory and pathological calcification pro-
cesses is currently widely accepted, and macrophages are known key players signaling extracel-
lular matrix (ECM) degradation, resident tissue cells differentiation and calcification [2, 6].
Although many aspects concerning the molecular mechanisms involved in pathological calcifi-
cation remain to be elucidated, features such as chronic inflammation, increased extracellular
matrix (ECM) remodeling, loss of anticalcific mechanisms leading to proliferation and differ-
entiation of resident cells, and the release of calcifying extracellular vesicles (EVs) are known
features contributing to the development of calcific lesions [7–11]. In atherosclerosis, early pla-
que calcification associates with macrophage accumulation, and macrophage infiltration and
inflammation have been shown to precede osteogenic conversion of vascular smooth muscle
cells (VSMCs) and the release of EVs [12, 13]. In osteoarthritis, synovium inflammatory and
destructive responses, leading to increased cartilage degradation and calcification, are largely
promoted by activated synovial macrophages [14–16]. Activated macrophages at sites of tissue
damage produce high levels of matrix metalloproteinases, cysteine endoproteases, cytokines,
and catabolic prostaglandins which will enhance elastin and collagen degradation leading to
remodeling and structural changes of the ECM, promoting calcification [12, 17, 18]. Moreover,
macrophages have been shown to regulate vascular calcification through the release of osteo-
genic factors capable of inducing VSMCs osteochondrogenic differentiation [2, 6]. It has been
recently proposed that macrophages release calcifying EVs loaded with mineralization related
factors, capable of accelerating ECM calcification [13]. In turn, increased matrix degradation
and calcification promote macrophage pro-inflammatory responses. Basic calcium phosphate
(BCP) crystals, which are the major forms of mineral crystals associated with both atheroscle-
rosis and osteoarthritis, can activate macrophages inducing proinflammatory responses with
increased tumor necrosis factor alpha (TNFα), interleukin-(IL) -1β and IL-8 cytokine produc-
tion [19]. Also, certain BCP-coated crystals, such as fetuin-A-containing calciprotein particles
(CPP), decrease macrophage cytokine production when compared to naked crystals [20]. It is
suggested that pathological calcification is not solely a passive consequence of chronic inflamma-
tory disease but is also involved in a positive feed-back loop of calcification and inflammation,
driving disease progression [2, 12, 14, 16]. Nevertheless, additional knowledge is required to
understand the crosstalk between the events leading to a calcification/inflammation pathological
feeding cycle. The identification of molecules involved in both processes would represent a
potential therapeutic value targeting calcification-related chronic inflammatory diseases. Vita-
min K, known to be critical for preventing soft tissue mineralization has been demonstrated to
be able to induce anti-inflammatory responses in macrophages playing a protective role against
inflammation [21–23]. Vitamin K is an essential cofactor for the post-translational modification
of vitamin K-dependent proteins (VKDPs), required for the modification of specific glutamic
acid (Glu) residues to calcium binding γ-carboxyglutamic acid (Gla) residues, in a reaction cata-
lysed by the γ-glutamyl carboxylase (GGCX) enzyme [24, 25]. Continuous recycling of the active
form of vitamin K is performed by vitamin K epoxide reductase (VKOR), which is inhibited
GRP is an anti-inflamatory agent in human monocytes/macrophages
PLOS ONE | https://doi.org/10.1371/journal.pone.0177829 May 18, 2017 2 / 23
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
by warfarin leading to impaired γ-carboxylation of VKDPs (as described in detail previously
[26]). Additional functions of vitamin K, such as anti-inflammatory, inhibitor of tumor pro-
gression, as well as transcriptional regulator of osteoblastic genes, have been recently pro-
posed as a direct effect of vitamin K, described to be independent of warfarin and formation
of Gla residues [27]. However, the association of VKDPs to these new vitamin K functions,
such as inflammation, has been poorly explored until now. Further knowledge on the role of
VKDPs in inflammatory processes should clarify the possible association of vitamin K in
inflammation related to γ-carboxylation.
Gla-rich protein (GRP) is the newest member of the VKDP family recently shown to be
involved in the crosstalk between inflammation and calcification of articular tissues in osteoar-
thritis [16]. Nevertheless, the involvement and relevance of GRP and its γ-carboxylation status
in the immune cells inflammatory responses has never been studied. We and others have pro-
posed GRP as a negative regulator of osteogenic differentiation [28], a modulator of calcium
availability in the ECM [29, 30], and an inhibitor of calcification in the cardiovascular [31]
and articular systems [16]. γ-carboxylation of GRP was demonstrated to be essential for its
calcification inhibitory function [16, 31], similarly to matrix Gla protein (MGP) that is widely
accepted to play a pivotal role in preventing soft tissue calcification and local mineralization of
the vascular wall and articular cartilage [25, 32]. Our previous studies also shown that down-
regulation of mediators of inflammation in chondrocytes and synoviocytes treated with GRP
is apparently independent of its γ-carboxylation status [16]. GRP calcium binding properties
[29, 33] and association to calcification processes [16, 30, 31, 34] indicate that its function
might be related with prevention of calcium-induced signaling pathways and to inhibition of
crystal formation/maturation by direct mineral-binding. Moreover, GRP is also involved in
the mineralization-competence of VSMCs-derived EVs possibly associated with the fetuin-
A-MGP calcification inhibitory system [31]. In this work, we aimed to study the capacity of
cells of the human immune system for the synthesis and carboxylation of GRP, and further
highlight the association of GRP with inflammatory responses of THP-1 monocyte/macro-
phage cells. Our results indicate GRP as an anti-inflammatory agent in monocytes/macro-
phages, and we suggest GRP as a new molecular link between inflammation and calcification,
with important implications on the development and progression of calcification-related
chronic inflammatory diseases.
Materials and methods
Ethics statement
Buffy coats from adult healthy volunteers were obtained at the national blood bank (IPST,
Instituto Português do Sangue e da Transplantac¸ão, Lisboa), after written informed consent of
all participants and approval by the “Conselho Directivo” of IPST. All principles of the Decla-
ration of Helsinki of 1975, as revised in 2000, were followed.
Isolation of human leukocytes
Peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells (PMNs) were iso-
lated using a Ficoll (Biochrom AG, Germany) gradient centrifugation, and contaminating
erythrocytes present in the PMN pellet were lysed with an ammonium chloride solution (0.8%
(w/v) NH4Cl, 0.1 mM EDTA, buffered with KHCO3 to pH 7.2–7.6) in a ratio 1:9 (v/v) cell sus-
pension/solution. Monocytes and T lymphocytes were independently isolated from the PBMC
fraction, by positive selection using MACS magnetic beads (Miltenyi Biotec, Germany) against
CD14 and CD3 respectively, following manufacturer’s instructions. Neutrophils were isolated
from the PMN fraction by negative selection, using EasySep Human Neutrophil Enrichment
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Kit (StemCell Technologies, France) according to manufacturer’s instructions. Each leukocyte
subset was obtained from 3 different donors (n = 3). The non-circulating leukocytes, mono-
cyte-derived macrophages and dendritic cells, were obtained by culturing monocytes accord-
ing to established protocols [35].
Flow cytometry
To confirm cell purity, isolated leukocyte subsets were analyzed by flow cytometry with an
Attune1 Acoustic Focusing Cytometer (Applied Biosystems) by accessing their dispersion
pattern or after staining with specific cell surface markers, such as anti-human CD3 antibody
(BioLegend, San Diego, CA, USA) to stain T lymphocytes, and anti-human CD16 antibody
(BD Biosciences, San Jose, CA, USA) to stain neutrophils.
Cell culture
Freshly purified monocytes were cultured in complete RPMI 1640 media (1% L-glutamine
(R&D Systems, Minneapolis, MN, USA), 10% heat-inactivated FBS, 1% penicillin-streptomy-
cin (PS), 1% non-essential amino acids and 1 mM sodium pyruvate (all from Sigma-Aldrich,
St. Louis, MO, USA)). For monocyte-derived cultures, cells were plated in 24 wells plate
(1×106 cells per well) in complete RPMI 1640 medium with 75 U/ml IL-4 and 1000 U/ml
recombinant human granulocyte macrophage colony-stimulating factor (GM-CSF) (both
from R&D Systems) for 6 days, to obtain monocyte-derived dendritic cells (MoDC), or with
1000U/ml GM-CSF (Peprotech, London, UK) for 7 days, to obtain monocyte-derived macro-
phages. Cultures were incubated at 37˚C in a 5% CO2 humidified atmosphere and fresh
medium was added every 2/3 days. THP-1 cell line was kindly given by Dr. Nuno Santos
(CBME, University of Algarve, Faro, Portugal) and was cultured according to ATCC instruc-
tions, in RPMI 1640 with L-Glutamine (Lonza, Visp, Switzerland), 10% heat-inactivated FBS
(Invitrogen, Carlsbad, CA, USA) and 1% PS (Thermo Scientific, Waltham, MA, USA). Differ-
entiation into macrophagic THP-1 (THP-1 MoM) was achieved by culturing cells in 25 ng/ml
of phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich) in complete RPMI for 48h.
Inflammatory stimulation assays
THP-1 and/or THP-1 MoM were seeded in 12-well plates at 1x106 cells and cultured during
12 h with media supplemented with 100 ng/ml of LPS (Sigma-Aldrich) or 250 μg/ml of syn-
thetic hydroxyapatite nano-crystals (HA) (Sigma). At determined time points cells were har-
vested for RNA extraction and quantification of gene expression, as described below.
Protein extraction
Leukocytes and cell lines total protein was obtained by extraction with RIPA buffer (50mM
Tris HCl pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%SDS) for 1h at 4˚C,
with agitation, followed by a centrifugation at 16 000 xg for 15 min at 4˚C. Protein concentra-
tion was assessed using Micro BCA kit (Thermo Scientific), according to the manufacturer’s
instructions.
Electrophoresis and Western blot
Aliquots of total protein extracts, ranging from 5 μg to 30 μg, were size separated in a 4–12%
(w/v) gradient polyacrylamide precast gel containing 0.1% (w/v) SDS (NuPage, Invitrogen,
Carlsbad, CA, USA)) and transferred onto a nitrocellulose membrane (Biorad, Richmond,
CA, USA). Western blot detection of tGRP, cGRP, tMGP, cMGP and GAPDH was performed
GRP is an anti-inflamatory agent in human monocytes/macrophages
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using specific primary antibodies CTerm-GRP (5 μg/ml), cGRP (1:1000 v/v) (GenoGla Diag-
nostics, Faro, Portugal), tMGP and cMGP (1:1000 v/v, both from VitaK BV, Maastricht, The
Netherlands) previously validated as described [16, 30, 31, 33, 34, 36], and anti-GAPDH (1:500
v/v) (Santa Cruz Biotechnology). Detection was achieved using species-specific secondary
horseradish peroxidase-conjugated antibodies and Western Lightning Plus-ECL (PerkinElmer
Inc., Waltham, MA, USA). Image acquisition was obtained using an IQ LAS 4000 mini biomo-
lecular imager (GE Healthcare, Lisbon, Portugal) and enhancement was performed with
Adobe Photoshop. Semi-quantification was performed using ImageJ software, and relative
protein levels normalized to GAPDH are presented as arbitrary units.
RNA extraction
Total RNA was extracted from purified and cultured leukocytes (3 donors) and cell lines
as described by Chomczynski and Sacchi [37]. Concentration of total RNA was deter-
mined by spectrophotometry at 260 nm and quality evaluated by agarose-denaturating gel
electrophoresis.
PCR analysis
One microgram of total RNA obtained from isolated leukocytes, THP-1 cell line, and 25 nano-
grams of total RNA isolated from exosomes were first treated with RQ1 RNase-free DNase
(Promega, Madison, WI, USA) according to manufacturer’s instructions and reverse tran-
scribed using Moloney-murine leukemia virus reverse transcriptase, RNase Out (both from
Invitrogen, Carlsbad, CA, USA), and an oligo(dT) adapter (5’-ACGCGTCGACCTCGAGATCG
ATG (T)13–3’), according to manufacturer’s recommendations. PCR reactions and set up
of technical replicates, were as follows: 5 μl of cDNA (from 1:10 or 1:5 cDNA synthesis), 0.6 μl
of forward and reverse primers (0.3 μM final concentration) (Table 1) and 10 μl of SsoFast™
EvaGreen1 Supermix (Bio-Rad) in reactions of 45 cycles. Fluorescence was measured at the
end of each extension cycle in the FAM-490 channel and the melting profiles of each reaction
were performed for monitoring of unspecific amplifications. Levels of gene expression were
calculated using the comparative method (ΔΔCt) and normalized using gene expression levels
of 18S or GAPDH housekeeping genes.
Anti-inflammatory assays
Purified and characterized fully γ-carboxylated GRP from sturgeon (A. Naccarii) [29] and
uncarboxylated recombinant human GRP produced in E. Coli [33], further referred as cGRP
and ucGRP, respectively, were used in these assays as previously described [16, 31]. For the
anti-inflammatory assays using LPS as inflammatory stimulating agent, THP-1 cells were
seeded in 96 well plates at a density of 2.5 x105 cells/well and differentiated as described above.
After differentiation, media was removed and cells were treated for 24 h with 0.5, 0.75 and
1.5 μg/ml of cGRP and ucGRP, followed by addition of 50 ng/ml of LPS for additional 24 h.
Dexamethasone treated cells (2 μM) were used as positive control. Conditioned media were
collected and anti-inflammatory activity was analyzed using commercially available ELISA
assays to measure TNFα (PreproTech) and PGE2 (Thermo Scientific) levels in cell superna-
tants, according to the manufacturer’s protocols. ELISA results were analyzed using a four
parameter logistic curve fitting model in GraphPad Prism software.
For the anti-inflammatory assay using BCP crystals and protein mineral complexes
(PMCs), BCP crystals were produced as previously described [16, 33] and sterilized overnight
at 180˚C to minimize endotoxins contamination. PMCs were prepared by incubating BCP
crystals, resuspended in RPMI media at 100 μg/ml, with approximately 750 ng/ml of cGRP/
GRP is an anti-inflamatory agent in human monocytes/macrophages
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ucGRP for 30 min at 37˚C [16]. 100 μg/ml of BCP crystals and PMCs (PMC-cGRP and PMC-
ucGRP), as well as 1.5 μg/ml of cGRP/ucGRP proteins alone, were added to differentiated
THP-1 as described above, for a period of 24 h (controls consist of non-treated THP-1 MoM
culture media). Conditioned media were collected and TNFα levels were measured using a
commercially available ELISA (Thermo Scientific) according to the manufacturer’s protocol.
Cell viability of THP-1-MoM supplemented with 50 ng/ml LPS, 1.5 μg/ml of cGRP and
ucGRP, 100 μg/ml of BCP crystals and PMC-cGRP/ucGRP, was determined at appropriate
times using the CellTiter 96 cell proliferation assay (Promega, Madison, WI, USA), following
manufacturer’s instructions.
Overexpression with GRP mRNA
The pCRII-TOPO/GRP clone [34] was used as template to PCR amplify the complete GRP
ORF using primers HSaGRPmMax_F, containing a T7 Polymerase promoter minimal
sequence and a kozak sequence upstream ATG initiation codon, and HuGRP_Ex5R (Table 1).
The resulting PCR product was used to in vitro synthetize capped and poly(A) tailed GRP
mRNA using the mMESSAGE mMACHINE T7 Ultra kit (Ambion, Life Technologies),
according to manufacturer’s recommendations. Final mRNA was recovered using Direct-zol
RNA Miniprep kit (Zymo Research, Irvine, CA, USA), and quantified by spectrophotometry
at 260 nm in a NanoDrop apparatus (Thermo Scientific). GRP mRNA transfection in THP-1
cells was performed with the jetMESSENGERTM transfection reagent according to manufac-
turer’s instructions. Briefly, 100.000 cells in 500 μl of culture media were seeded per well in a
24-well plate 24 h before transfection. Transfection was performed using 0.5 μg mRNA/well
following recommendations, and GRP gene expression analysis was performed in cells
Table 1. Gene-specific primers used in this study.
Gene Primer name Sequence (5’ to 3’)
18S 18S_F GGAGTATGGTTGCAAAGCTGA
18S_R ATCTGTCAATCCTGTCCGTGT
GAPDH GAPDH_F AAGGTGAAGGTCGGAGTCAACGGA
GAPDH_R TCGCTCCTGGAAGATGGTGATGGG
GRPF GRPF1_F GTCCCCCAAGTCCCGAGATGAGG
GRPF1_R CCTCCACGAAGTTCTCAAATTCATTCC
MGP MGP_F TGGAGGCTGGCACCTGATTTTG
MGP_R AAAAGGGGTGCAGCCAGACAAG
GGCX GGCX_F TTACACAGAGTCGGCGATGGAAGGAT
GGCX_R TACTGGATGTCAGGTCTGCGAAA
VKOR VKOR_F AGGGCAAGGCTAAGAGGCACTGAG
VKOR_R CTGGGCAATGGAAAGAGCTTTGGAGAC
IL-1β IL-1β_F TGGACAAGCTGAGGAAGATGCTGGT
IL-1β_R CCCTGGAGGTGGAGAGCTTTCAGTT
TNFα TNFα_F AGGGCCTGTACCTCATCTACTCCCA
TNFα_R AGCTGGAAGACCCCTCCCAGATAGA
NFkB NFkB_F GCAATCATCCACCTTCATTCTCAACTT
NFkB_R CCTCCACCACATCTTCCTGCTTAG
GRP(synthetic mRNA) HSaGRPmMax_F* GCTAATACGACTCACTATAGGGACAGGTCACCATGACTTGGAGACAGGCCGTCCTGCTGT
HuGRP_Ex5R ACACGGGGATGCCAATGGTGCTAC
*Underlined sequence, T7 Polymerase promoter minimal sequence; bold sequence, kozak sequence.
https://doi.org/10.1371/journal.pone.0177829.t001
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harvested for RNA extraction at 24, 48 and 72 h post-transfection by qPCR as described above.
For anti-inflammatory assays, THP-1 cells were transfected as described, and after 24 h cells were
stimulated with 50 ng/ml of LPS during 12 h, and 250 μg/ml of HA (Sigma) during 48 h. At deter-
mined time points, cells were harvested for RNA extraction and quantification of gene expression
of the target inflammatory genes IL-1β, TNFα and NFkB, as described above (Table 1). Condi-
tioned media were collected and TNFα levels were measured using a commercially available
ELISA (PreproTech) according to the manufacturer’s protocol.
Extracellular vesicles isolation
THP-1 were differentiated as described above with 25 ng/ml PMA in complete RPMI using
exosome-depleted FBS [31] for 48 hours, followed by culture with serum starvation for another
20 hours. Conditioned medium was collected and EVs were isolated as described [31]. Briefly,
EVs from media were fractionated through differential centrifugation at 2.000 xg for 15 min,
10.000 xg for 1h, 30.000 xg for 1h and 100.000 xg for another 2h. Recovered supernatant after
30.000 xg was filtrated through a 0.2 μm filter before centrifugation at 100.000 xg. All centrifu-
gations were carried at 4˚C. Final pellets were washed with PBS, pelleted again and ressus-
pended in PBS. Total RNA of isolated vesicles was obtained using Direct-zol RNA Miniprep
kit (Zymo Research, Irvine, CA, USA), according to manufacturer’s instructions. Detection of
CD9 (Invitrogen), tGRP and GAPDH was performed by Western blot as described above.
Transmission Electron Microscopy (TEM)
EVs isolated by differential ultracentrifugation at 100.000 xg were adsorbed onto formvar-car-
bon coated grids and stained with 1% aqueous uranyl acetate. The grids were air dried before
observation in a JEOL 1200EX transmission electron microscope.
Statistical analysis
Data are presented as mean (n>2) ± standard error. Significance was determined for more
than two groups using ordinary one-way ANOVA with either comparison between groups by
Dunnett test or multiple comparisons with the Tukey’s test. Student’s t-test was used for com-
parison between two groups. The non-parametric Mann-Whitney U test was performed to
confirm the difference of two group comparison. Statistical significance was defined as P< =
0.05 (), P< = 0.01 (), P< = 0.001 (), and P<0.0001 ().
Results
γ-carboxylated GRP and MGP are present in circulating leukocytes
To investigate whether human leukocytes express the vitamin K-dependent protein GRP and
their γ-carboxylation capacity, different human blood leukocyte subsets were isolated, and
used to evaluate GRP gene expression and protein γ-carboxylation status. In addition, since
MGP has been previously detected in macrophage foam cells in vivo [38], and shown to be up-
regulated in RAW 264.7 mouse macrophage cells upon inflammatory stimulation with
VSMCs conditioned media [6], prompted us to simultaneously study MGP as a related VKDP,
potentially γ-carboxylated in leucocytes. Isolated leucocyte subsets of circulating neutrophils
(Neut), monocytes (Mon) and T lymphocytes (T lym) were analyzed by flow cytometry and
showed purity levels above 96% for each population (results not shown). Macrophages (Mac)
and dendritic cells (DC) were obtained by differentiation from isolated monocytes, and cell
differentiation was determined based on the observed gain of cell adherence (Mac) or den-
dritic (DC) under optic microscope observation (results not shown). Gene expression analysis
GRP is an anti-inflamatory agent in human monocytes/macrophages
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by qPCR revealed the presence of both GRP and MGP mRNA in all leukocytes subsets tested
(Fig 1A). In order to confirm the presence of GRP and MGP at the protein level in the major
circulating leukocytes: monocytes, T lymphocytes and neutrophils, total protein extracts were
analyzed by Western blot using previously validated antibodies for total GRP and MGP, and
conformation specific antibodies for the detection of the specific γ-carboxylated forms [16, 30,
31, 33, 34, 36]. Positive GRP and MGP signals were detected in all the three cell subsets, using
CTerm-GRP and tMGP antibodies, respectively (Fig 1B). Interestingly, different migration
patterns were observed among the different leukocytes cell subsets for both GRP and MGP.
While positive signal in monocytes (Mon) and neutrophils (Neut) was predominantly
observed at 15 and 25 kDa, T lymphocytes (T-Lym) shown three positive bands ranging
from 14 kDa to 20 kDa for both GRP and MGP (Fig 1B). Since the presence of Gla residues
in these VKDPs has been demonstrated as a functional requirement, detection of γ-carbox-
ylated GRP and MGP in the leukocytes subsets was further performed using conforma-
tional-specific cGRP and cMGP antibodies, respectively (Fig 1B). Positive signals were
detected for both cGRP and cMGP with similar signal profiles to those obtained with anti-
bodies for the total protein (tMGP and tGRP) (Fig 1B). Protein integrity on the RIPA
extracts were evaluated by CBB staining after SDS-PAGE analysis, and detection of GAPDH
by Western blot (results not shown). A similar detection pattern of GRP with multiple posi-
tive bands, using the CTerm-GRP and cGRP antibodies, was previously obtained in protein
extracts from calcified aortic valves, where GRP identity was further confirmed by LC-MS/
MS [31]. Since γ-carboxylation reaction machinery is a multi-component enzyme depen-
dent reaction that includes VKOR and GGCX enzymes, the presence of these genes was also
evaluated. Gene expression for both enzymes was confirmed in all the circulating leukocytes
cell subsets analyzed (Fig 1C), further corroborating the capacity of these human leukocyte
cells to γ-carboxylate GRP and MGP.
THP-1 cell line is a suitable model for studying VKDPs in leukocytes
Since monocytes and macrophages are key players during inflammation and particularly associ-
ated to calcification related chronic inflammatory diseases [1–5], we decided to assess if THP-1
monocytic cell line could be used for further studies involving the association of GRP with
inflammatory processes. The protein and gene profiles of GRP and MGP were analyzed and
compared with its biological human cell counterpart. The presence of mRNAs for GRP, MGP,
as well as for the γ-carboxylation related enzymes GGCX and VKOR, was detected by RT-PCR
in both THP-1 and differentiated macrophage THP-1 (THP-1 MoM) (Fig 2A). Western blot
analysis of THP-1 and THP-1 MoM protein extracts shown detection of γ-carboxylated GRP
and MGP in both cell cultures, with similar patterns among monocytic and macrophagic states
(Fig 2B). However, dissimilar migration profiles for both cGRP and cMGP were found between
THP-1 (Fig 2B) and biological monocytic cells (Fig 1B), which might be related to different γ-
carboxylation degrees reflecting putative differences between γ-carboxylation capacity of the in
vivo and in vitro systems [29]. Nevertheless, the production of γ-carboxylated GRP in THP-1
and THP-1 MoM cells indicates the suitability of using these cells to further study the involve-
ment of GRP in monocytes/macrophages inflammatory mechanisms.
GRP and MGP are up-regulated in LPS- stimulated THP-1 monocytes
and macrophages
Since GRP has been previously associated with inflammatory events in chondrocytes and
synoviocytes [16], and MGP was recently shown to be up-regulated, together with IL-1β,
in RAW 264.7 cells after treatments with VSMCs conditioned media [6], we studied the
GRP is an anti-inflamatory agent in human monocytes/macrophages
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Fig 1. GRP and MGP are produced by leukocytes as γ-carboxylated proteins. Leukocyte subsets
neutrophils (Neut), monocytes (Mon), and T lymphocytes (T-Lym) were isolated from human buffy coats, and
macrophages (Mac) and dendritic cells (DC) were obtained by differentiation of isolated monocytes in culture.
After purity assessment by flow cytometry, these isolated leukocyte populations were used to evaluate GRP
GRP is an anti-inflamatory agent in human monocytes/macrophages
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involvement of GRP and MGP in monocytes/macrophages inflammatory responses using
undifferentiated and differentiated THP-1 cell line, stimulated with LPS. Maximum in-
flammatory response of THP-1 monocytes to LPS was detected after 3 h by significant up-
regulation of IL-1β, followed by a progressive decrease until 12 h (Fig 3A). The pattern of
GRP maximum level of expression was obtained just 1 h after LPS stimulation, progres-
sively decreasing until control levels at 12 h, while MGP level of expression was found simi-
lar to IL-1β, with an expression peak at 3 h (Fig 3A). Interestingly, only a slight but gradual
increase in GGCX expression was found during stimulation, with levels close to non-stim-
ulated cells until 6 h, and a significant decrease at 12 h (Fig 3A). The inflammatory respon-
se of THP-1 macrophages appeared to be delayed compared to that of THP-1 monocyte
cells, as previously reported [39] with maximum up-regulation of IL-1β only at 12 h after
LPS stimulation (Fig 3B). GRP and MGP expression profiles in macrophages were found
highly similar, with a peak detected at 6 h, and a significant decrease at 12 h, while an up-
regulation of GGCX was found at 6 h and maintained until 12 h with similar levels (Fig
3B). These results indicate that GRP and also MGP are involved in the endogenous inflam-
matory response mechanisms of monocytes and macrophages. In addition, a correlation
between increased levels of GRP and MGP, and up-regulation of GGCX was observed in
macrophages, suggesting the involvement of γ-carboxylation in the inflammatory mecha-
nism mediated by VKDPs such as GRP and MGP.
and MGP production at gene and protein levels. (A) Relative fold expression (arbitrary units) of GRP and
MGP determined by qPCR in isolated leukocytes. Means are presented as replicates of 3 biological healthy
donors using 18S as housekeeping gene. (B) Total protein extracts of the isolated leukocyte populations were
obtained with RIPA buffer and quantified using the Micro BCA kit. Five μg, ten μg and fifteen μg of total protein
extracts from T Lym, Mon and Mac, respectively, were analyzed by Western blot to detect total GRP (tGRP)
and total MGP (tMGP) protein forms using the validated CTerm-GRP and tMGP antibodies, and γ-
carboxylated GRP (cGRP) and MGP (cMGP) protein forms using conformation-specific antibodies. Position
of relevant molecular mass markers (kDa) is indicated on the left side. (C) Qualitative gene expression
analysis of the γ-carboxylated related enzymes VKOR and GGCX by RT-PCR in T lymphocytes, monocyte
and neutrophils. 18S amplification was used as loading control for sample integrity.
https://doi.org/10.1371/journal.pone.0177829.g001
Fig 2. γ-carboxylated GRP and MGP are produced in THP-1 cell line. THP-1 and THP-1 MoM differentiated
with 25 ng/ml of PMA during 48h were cultured in control conditions and harvested for RNA and protein extraction.
(A) Qualitative gene expression analysis of GRP, MGP, VKOR and GGCX by RT-PCR in undifferentiated THP-1
representing monocyte cells (THP-1), and in differentiated THP-1 representing macrophages (THP-1 MoM). (B)
Western blot analysis of thirty μg of total RIPA protein extracts of THP-1 and THP-1 MoM cells using the con-
formation-specific antibodies recognizing γ-carboxylated GRP (cGRP) and MGP (cMGP). Position of relevant
molecular mass markers (kDa) is indicated on the right side.
https://doi.org/10.1371/journal.pone.0177829.g002
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Fig 3. GRP and MGP are up-regulated in LPS stimulated THP-1 cells. THP-1 and differentiated THP-1 macrophage cells were stimulated with 100 ng/
ml of LPS and harvested for RNA extraction at determined time points during 12h. Relative gene expression analysis of the inflammatory marker IL-1β,
GRP, MGP and GGCX was determined by qPCR in monocytes (THP-1 cells) (A) and in differentiated THP-1 macrophages (B) at indicated time points.
Gene expression levels are relative to the expression of control untreated cells during each time point. GAPDH was used as housekeeping gene and data is
presented as means (n = 4) ± standard error of duplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple comparisons
were achieved with Tukey’s test. Statistical significance was defined as P< = 0.05 (*), P< = 0.01 (**), P< = 0.001 (***) and P<0.0001 (****).
https://doi.org/10.1371/journal.pone.0177829.g003
Fig 4. GRP and MGP are up-regulated in hydroxyapatite stimulated THP-1 MoM cells. Differentiated THP-1 macrophage cells were stimulated with
250 μg/ml of synthetic hydroxyapatite nano-crystals and harvested for RNA extraction at determined time points during 12h. Relative gene expression
analysis of the inflammatory marker IL-1β, GRP and MGP was determined by qPCR at indicated time points. Gene expression levels are relative to the
expression of control untreated cells during each time point. GAPDH was used as housekeeping gene and data is presented as means (n = 3) ± standard
error of duplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple comparisons were achieved with Tukey’s test.
Statistical significance was defined as P< = 0.05 (*), P< = 0.01 (**), and P< = 0.001 (***).
https://doi.org/10.1371/journal.pone.0177829.g004
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Hydroxyapatite induces a pro-inflammatory response of THP-1
macrophages and an up-regulation of GRP and MGP
To determine the effect of hydroxyapatite (HA) on macrophage cells and the corresponding
expression patterns of GRP and MGP, synthetic HA nano-crystals were used to stimulate
THP-1 MoM cells over a 12 h period. Progressive increase in IL-1β indicate that HA induced a
pro-inflammatory response of THP-1 MoM cells, while up-regulation of GRP and MGP was
observed at 3 h of HA treatment (Fig 4).
GRP decreases the pro-inflammatory response of LPS-stimulated
macrophagic THP-1 cells
Our results showing a correlation between GRP and GGCX expression in macrophages (Fig
3B), suggest the involvement of γ-carboxylation in the inflammatory response. In order to fur-
ther determine if GRP could have a direct effect on the LPS-stimulated immune function of
THP-1 cells and to further unveil the modulatory effect of its γ-carboxylation state, THP-1
MoM cells were treated with increasing concentrations of purified cGRP/ucGRP previously
used in functional assays [16, 31], or dexamethasone (DXM) during 24 h, followed by exposure
to LPS. Inflammatory responses were determined by measuring TNFα accumulation in cell
media (Fig 5A). When compared to the control condition, LPS stimulated cells showed a sig-
nificant increase in TNFα production while cells treated with the control anti-inflammatory
agent DXM showed a significant decrease in the levels of TNFα. Treatments with ucGRP
resulted in a dose-dependent decrease of TNFα levels relative to LPS treated cells, with a maxi-
mum decrease achieved at 1.5 μg/ml of ucGRP (Fig 5A). Treatments with cGRP also shown
decreased TNFα levels although to a less extent and independent of the concentrations used
(Fig 5A). These results were further confirmed by measuring the PGE2 production in a similar
experiment setting using 1.5 μg/ml of ucGRP/cGRP (Fig 5B). Again, the highest inhibitory
effect on PGE2 production was obtained with ucGRP when compared with the same treat-
ments using cGRP (Fig 5B). THP1-MoM cell viability was unaffected in the presence of LPS
and ucGRP or cGRP at 1.5 μg/ml (results not shown).
Coating of BCPs with GRP attenuates the pro-inflammatory response of
THP-1 macrophages
Since BCPs coated with GRP were able to decrease the inflammatory response of chondrocytes
and synoviocytes when compared to naked crystals [16], we studied the effect of BCPs coated
with either cGRP/ucGRP (PMCs) in the macrophage THP-1 pro-inflammatory reaction. As
expected, BCP crystals induced the production of TNFα when compared to non-stimulated
cells (Fig 6). However, PMCs containing either cGRP or ucGRP resulted in a decrease on
TNFα levels and interestingly, the highest effect was observed with PMCs-cGRP (Fig 6). As a
control, cGRP/ucGRP were added to the culture media of control non-stimulated cells and
showed no effect on TNFα production (Fig 6). THP1-MoM cell viability was unaffected in the
presence of tested BCPs and PMC-ucGRP or PMC-cGRP (results not shown).
GRP overexpression decreases THP-1 inflammatory response to LPS
and HA stimulation
To further study the anti-inflammatory capacity of endogenous GRP, THP-1 cells were tran-
siently transfected with in vitro transcribed GRP mRNA. To determine the time required to
achieve GRP overexpression, a time course study was performed at 24, 48 and 72 h post-trans-
fection. Quantification of GRP mRNA levels by qPCR shown sustained overexpression from
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24 to 72 h (Fig 7A), and Western blot analysis confirmed increased protein accumulation in
transfected cells (Fig 7B). Non-transfected (C) and transfected (T) THP-1 cells were then cul-
tured in control conditions and stimulated with LPS [non-transfected cells stimulated with
LPS (C-LPS); transfected cells stimulated with LPS (T-LPS)]. While overexpression of GRP
was confirmed in control transfected cells, levels of GRP mRNA were further upregulated
upon stimulation with LPS (Fig 7C). The inflammatory response in the presence of increased
intracellular levels of GRP was evaluated through gene expression of inflammatory marker
genes and measurements of TNFα accumulation in conditioned media. Down-regulation of
the inflammatory markers IL-1β and NFkB were found in transfected cells when stimulated
with LPS relative to non-transfected cells (Fig 7D and 7E). Levels of TNFα at gene (Fig 7F) and
protein (Fig 7G) levels, were found similar in non-transfected and transfected THP-1 cells cul-
tured in control conditions, while LPS-stimulated cells shown decreased levels of TNFα in
transfected cells when compared to non-transfected.
Stimulation of THP-1 cells with HA shown similar overexpression levels of GRP mRNA in
non-stimulated and stimulated transfected cells (Fig 8A), while down-regulation of NFkB and
TNFα gene expression was observed in HA stimulated THP-1 overexpressing GRP (Fig 8B
and 8C). In concordance, decreased levels of secreted TNFα were obtained in transfected cells
stimulated with HA when compared to stimulated non-transfected cells (Fig 8D).
These results shown that increased expression of GRP is capable of decreasing the inflam-
matory responses of THP-1 cells induced by LPS and HA, acting as an endogenous anti-
inflammatory and protective agent.
Fig 5. GRP reduces TNFα and PGE2 production in THP-1 MoM cells stimulated with LPS. (A) Differentiated THP-1 MoM cells were treated with
0.5 μg/ml, 0.75 μg/ml and 1.5 μg/ml of purified cGRP and ucGRP proteins for 24 h, followed by exposure to 50 ng/ml LPS for additional 24 h. Cells
treated with 2 μM dexamethasone (DXM) were used as a positive anti-inflammatory control, and non-stimulated cells (C) as controls to LPS stimulation.
Conditioned cell culture media were collected and used to determine TNFα accumulation by ELISA assays. Data are presented as means (n = 3) ±
standard error of triplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple comparisons were achieved with
Dunnett’s test. Statistical significance was defined as P< = 0.05 (*), P< = 0.01 (**), and P< = 0.001 (***). (B) Differentiated THP-1 MoM cells were
treated with 1.5 μg/ml of purified cGRP and ucGRP proteins for 24 h and exposed to LPS as described in (A), and PGE2 accumulation was determined in
conditioned media through ELISA assays. Data are presented as means (n = 2) ± standard error of replicates of two independent experiments. Ordinary
one-way ANOVA was used and multiple comparisons were achieved with Dunnett’s test. Statistical significance was defined as P< = 0.001 (***) and
P<0.0001 (****).
https://doi.org/10.1371/journal.pone.0177829.g005
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GRP is present in extracellular vesicles secreted by THP-1
macrophages
Since extracellular vesicles (EVs) are known to be released by macrophages [13], and GRP was
recently shown to be present in EVs derived from VSMCs and implicated in the vascular calci-
fication process [31], we further explored the association of GRP with THP-1 MoM released
EVs. EVs isolated from serum-starved THP-1 MoM through differential ultracentrifugation at
100.000 xg (100K) were characterized by TEM and Western blot analysis (Fig 9A and 9B).
TEM analysis of the 100K population showed a homogeneous population of small particles
with an average size of 30 nm (Fig 9A) and positive for cluster of differentiation 9 (CD9) and
GAPDH, as determined by Western blot (Fig 9B). Interestingly, GRP was detected in the 100K
isolated EVs both at protein (Fig 9B) and mRNA levels (Fig 9C). The detected protein pattern
was similar to that of THP-1 MoM cell lysates (Fig 2B) with a predominant band at 20 kDa,
and the presence of GRP and MGP mRNA in EVs was qualitatively determined by RT-PCR of
EVs isolated total RNA (Fig 9C).
Discussion
1. In this work, we demonstrated that GRP and MGP are expressed and translated by
human leukocytes subsets as γ-carboxylated vitamin K-dependent proteins, which can
be released into circulation or peripheral tissues, as extracellular vesicles components.
GRP was shown to be involved in the inflammatory mechanism response, functioning
as an endogenous and exogenous anti-inflammatory agent in THP-1 and THP-1 MoM
stimulated cells. Interestingly, while γ-carboxylation can be an active process in immune
Fig 6. Coating of BCPs with GRP reduces TNFα production in THP-1 MoM when compared with naked
crystals. Differentiated THP-1 MoM cells were treated with 100 μg/ml of BCP crystals or BCPs-coated with
cGRP/ucGRP (PMC/cGRP; PMC/ucGRP) proteins for 24 h, and non-stimulated cells were used as control
(C). Control non-stimulated cells were also treated with 1.5 μg/ml of cGRP/ucGRP proteins for comparison.
Conditioned media were collected and used to determine TNFα accumulation through ELISA assays. Data
are presented as means (n = 3) ± standard error of triplicates of two independent experiments. Ordinary one-
way ANOVA was used and multiple comparisons were achieved with Dunnett’s test. Statistical significance
was defined as P< = 0.01 (**) and P<0.0001 (****).
https://doi.org/10.1371/journal.pone.0177829.g006
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Fig 7. Overexpression of GRP in THP-1 cells rescues LPS induced inflammation. THP-1 cells were transiently transfected with GRP mRNA during 24,
48 and 72 h, and GRP overexpression was evaluated by measuring levels of GRP mRNA (A) and protein production (B). (A) GRP Normalized expression
was determined by qPCR in non-transfected (C) and transfected (T) cells at the indicated time points. Data are presented as means (n = 3) ± standard error
of duplicates of two independent experiments. Student’s t-test was used for comparison between C and T groups at each time point. Statistical significance
was defined as P< = 0.001 (***). (B) Twenty micrograms of total protein extracts from the conditions described above were analysed by Western blot to
detect tGRP and GAPDH proteins, and relative protein levels normalized to GAPDH were obtained using ImageJ software and are presented as arbitrary
units. (C-G) Transfected (T) and non-transfected THP-1 (C) cells were cultured for 24 h and either maintained in control conditions (C, T) or stimulated with
LPS (C-LPS, T-LPS) for additional 12 h. Normalized GRP gene expression was determined by qPCR (C), and inflammatory response was evaluated by
measuring gene expression of the inflammatory markers IL-1β (D) NFkB (E) and TNFα (F) and TNFα accumulation in cell culture media by ELISA (G). (C-F)
Data are presented as means (n = 6) ± standard error of triplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple
comparisons were achieved with Tukey’s test. Statistical significance was defined as P< = 0.01 (**), P< = 0.001 (***) and P<0.0001 (****). ns, non-
significant. (G) Data is presented as means (n = 4) ± standard error of triplicates of two independent experiments. Ordinary one-way ANOVA was used and
multiple comparisons were achieved with Dunnett’s test. Statistical significance was defined as P< = 0.001 (***) and P<0.0001 (****).
https://doi.org/10.1371/journal.pone.0177829.g007
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cells, this post-translation modification doesn’t seem to be a critical factor for the GRP
anti-inflammatory activity.
GRP has been associated with mineralization processes in several ectopic calcification-associ-
ated diseases [16, 30, 31, 33, 34], and shown to act as a calcification inhibitor in vascular and
articular tissues [31, 16]. More recently, we have shown that GRP is also involved in inflamma-
tory processes in osteoarthritis, acting as an anti-inflammatory agent in both chondrocytes
and synoviocytes [16], although its involvement in the immune cells inflammatory response
still remained unknown. The presence of GRP in all leukocytes subsets tested suggests that it is
a constitutive component of immune cells and might be involved at different levels in the
Fig 8. Overexpression of GRP in THP-1 cells rescues hydroxyapatite induced inflammation. THP-1 cells were transiently transfected
with GRP mRNA for 24 h and either maintained in control conditions (C, T) or stimulated with HA (C-HA, T-HA) for additional 48 h. Gene
expression of GRP (A) and the inflammatory marker genes NFkB (B) and TNFα (C) were determined by qPCR (A), and levels of TNFα
accumulation were measured by ELISA in conditioned culture media (D). (A-C) Data are presented as means (n = 6) ± standard error of
triplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple comparisons were achieved with Tukey’s test.
Statistical significance was defined as P< = 0.01 (**), P< = 0.001 (***) and P<0.0001 (****). ns, non-significant. (D) Data are presented as
means (n = 4) ± standard error of triplicates of two independent experiments. Ordinary one-way ANOVA was used and multiple comparisons
were achieved with Dunnett’s test. Statistical significance was defined as P< = 0.001 (***) and P<0.0001 (****).
https://doi.org/10.1371/journal.pone.0177829.g008
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human immune system. In concordance, GRP has been previously detected in foam macro-
phages in calcific aortic valve disease [31], and co-localized with CD45 in osteoarthritic syno-
vial membrane, characterized by lymphocytes and plasma cells infiltration [16]. Since in a
context of ectopic calcification-dependent diseases, such as atherosclerosis and osteoarthritis,
monocytes and macrophages are key players in disease initiation and progression, our focus
was given to study the role of GRP in these particular immune cells. For that, we have used the
THP-1 cell line that is the most widely used model for in vitro studies of primary human
monocytes/macrophages, allowing the investigation on the function and regulation of mono-
cytes and macrophages, overcoming the experimental limitations of using non-proliferative
and short life spanning human primary macrophages [40]. As recently proposed, the function
of GRP as a mediator factor linking mineralization and inflammatory processes might not be
exclusively mediated by mineralization events [16]. Here, using the THP-1 monocytes/macro-
phages cell line, we shown that GRP expression is up-regulated under inflammatory stimula-
tion with both LPS and hydroxyapatite. Also, treatments of THP-1 macrophage cells with
purified cGRP/ucGRP or with BCPs coated with either cGRP/ucGRP (PMCs), resulted in
decreased levels of TNFα or PGE-2 production. Moreover, GRP overexpression is able to
counteract the inflammatory response of THP-1 when stimulated with either LPS or HA.
These results strongly indicate an anti-inflammatory function of GRP, acting not only as an
exogenous agent but also as an endogenous factor involved in inflammatory response mecha-
nisms and providing a protective effect. Calcification and inflammation processes are widely
known to be intimately correlated, with macrophages playing a key role due to their contribu-
tion to matrix degradation and calcification through the release of pro-inflammatory cyto-
kines, prostaglandins and/or production of osteogenic factors [2, 6, 13, 19, 41, 42]. The
accumulation of macrophages within the vascular wall has been regularly co-localized with cal-
cium deposits and shown to have an important role in the initiation of atherosclerosis develop-
ment and vascular calcification [12, 13]. Soluble factors produced by activated macrophages
have been shown to promote osteochondrogenic differentiation of VSMCs increasing the pro-
duction of osteoblast-like factors such as BMP-2 and decreasing mineralization inhibitors such
as MGP, ultimately leading to increased calcium mineral deposition [2, 6]. On the other hand,
micro-calcifications have been proposed to be involved in macrophage recruitment in early
stages of atherosclerosis [43], and BCP crystals shown to stimulate the production of pro-
inflammatory cytokines by macrophages, which affect VSMCs differentiation, in a calcifica-
tion-inflammation pathological feeding cycle [19 and described in detail previously [44]]. In
Fig 9. GRP is present in THP-1 MoM extracellular vesicles (EVs) at protein and mRNA levels. EVs were
isolated from THP-1 MoM cell conditioned media by differential ultracentrifugation at 100.000 xg and
characterized by TEM (A), Western blot for the exosomal marker CD9, GAPDH and total GRP (tGRP) (B),
and qualitative analysis of GRP, MGP and GAPDH mRNA (C). Scale bar in panel (a) represents 200 nm.
https://doi.org/10.1371/journal.pone.0177829.g009
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this context it is conceivable that GRP produced by monocytes/macrophages at sites of calcifi-
cation might contribute to the high levels of protein accumulation previously detected at sites
of mineral deposition [16, 31]. Moreover, the GRP anti-mineralization function described as a
direct effect of the protein as a modulator of crystal formation and/or growth [16], could also
be related with its anti-inflammatory action, by decreasing macrophage cytokine production
and consequent decrease in cell differentiation and calcification events at tissue and cell levels.
In concordance, GRP was shown to mediate monocyte and macrophage pro-inflammatory
responses by decreasing the production of inflammatory mediators such as TNFα, PGE2 and
IL1β, and the transcription factor NFkB. The release of TNFα by activated macrophages has
long been reported to affect atherosclerosis, VSMCs osteogenic activity and calcification, exert-
ing multiple effects during atherogenesis, including increasing permeability of endothelial
cells, promoting monocyte adhesion, inducing macrophage differentiation, and promoting
foam cell formation. Inhibition of TNFα in ApoE(-/-) mice was shown to reduce by 50% the
size of aorta lesions [45]. TNFα has a pivotal role in enhancing VSMCs calcification through
the activation of NFκB, leading to a decreased expression of ankyloses protein homolog
(ANKH) that controls pyrophosphate (PPi) efflux, accompanied by a reduction in PPi export
[46]. In addition, TNFα and IL-1β are reported to enhance VSMCs osteogenicity by increasing
BMP-2 and reducing MGP expression [6]. Prostaglandin E2 (PGE2) has been implicated in
the instability of atherosclerotic plaques and COX-2 expression was found to be up-regulated
in human aortic valve interstitial cells from stenotic valves than in control AVICs [47, 48].
Also, the production of catabolic and pro-inflammatory mediators, including cytokines, che-
mokines, cyclooxygenase-2 (COX-2), PGE2 and inducible nitric oxide synthase (NOS2), is
widely reported to promote the destruction of the cartilage matrix and joint function loss in
OA [49]. In this line, we propose that GRP is involved in the feed-back loop between inflam-
mation and calcification, as a molecular link between macrophage-released osteogenic factors
and calcification-related agents modulating inflammation.
Interestingly, although γ-carboxylation of GRP has been shown as essential for its role as
mineralization inhibitor [16, 31], its anti-inflammatory activity was found to be independent
of its γ-carboxylation status in articular tissues [16]. Similarly, our results show decreased levels
of TNFα and PGE2 in THP1-MoM cells treated with either cGRP/ucGRP proteins, or PMCs-
cGRP/PMCs-ucGRP, but the significance of its γ-carboxylation in inflammatory reactions is
presently unclear, and should be further evaluated. Despite the widely accepted anti-inflamma-
tory effect of vitamin K [21–23, 27], the role and involvement of VKDPs in immune cells has
been poorly explored. Dietary supplementation of vitamin K were shown to suppress LPS-
induced inflammation [21], and vitamin K status has been associated with lower concentra-
tions of inflammatory markers in vivo [22, 27]. In vitro, vitamin K has been associated with
decreased production of pro-inflammatory cytokines, such as TNFα, IL-1β, IL-6, and osteo-
protegerin, and proposed to be mediated via the inactivation of NFkB signalling pathway,
independent of its Gla formation activity [23, 27]. These in vitro studies not only suggest a
direct effect of vitamin K, not related with the carboxylation of VKDPs, but also propose that
the anti-inflammatory mechanism is associated with the vitamin K protective effect against
oxidative stress [27]. In this study, we have demonstrated that γ-carboxylation-related machin-
ery such as GGCX and VKOR genes are expressed in major circulating leukocytes. Moreover,
using previously validated conformational-specific antibodies [16, 30, 31, 33, 34, 36], we were
able to show that γ-carboxylated GRP and MGP are produced by these immune cells. Never-
theless, controversial data has been reported concerning the effect of warfarin on the immune
system, described to act as an anti-inflammatory, pro-inflammatory, or not related agent [27,
50, 51]. Altogether, these data clearly emphasize the need for additional molecular studies to
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unveil the activity of GRP in the inflammatory process and further evaluate the modulating
potential of its γ- carboxylation status.
Increased concentrations of calcium and phosphate were shown to induce macrophage
release of matrix vesicles (MVs) with high calcification potential that participate in the initia-
tion of microcalcification [13]. γ-carboxylation of GRP and MGP might be associated with
macrophage action on calcification through the recently proposed mechanisms involving the
release of calcifying MVs [13]. Our results have shown that THP-1 MoM extracellular vesicles
(EVs), similarly obtained by differential ultracentrifugation at 100.000 xg, contain GRP. We
had previously demonstrated that GRP is a new player in the mineralization competence of
VSMCs derived-EVs from aortic segments [31]. In fact, the release of EVs capable of efficiently
nucleate hydroxyapatite has been demonstrated as a key event in the initiation of both physio-
logical and pathological calcification in VSMCs and chondrocytes [8, 10, 52]. Under normal
conditions, VSMCs-derived EVs do not calcify because of their loading with mineralization
inhibitors acting to block mineral nucleation, and loss of functional mineralization inhibitors
such as GRP, cMGP and fetuin A is crucial to promote EVs calcification [8, 10, 31, 52]. γ-car-
boxylation of MGP and GRP has been demonstrated as crucial for adequate mineralization
inhibition in both VSMCs and chondrocytes, and increasing undercarboxylated MGP accu-
mulation promote EVs mineralization [16, 31, 10, 52]. Interestingly, foam cells found at
regions of lipid accumulation in atheromas surrounding areas in calcified aortic valve disease,
mainly produce ucGRP [31]. The presence of GRP in macrophage-derived EVs might repre-
sent a secretion pathway to tissue calcification sites and/or a modulating role on the calcifica-
tion potential of macrophage-derived EVs. Additionally, we found mRNA for GRP and MGP
on the EVs isolated from macrophages. EVs, particularly exosomes, are known to carry genetic
material such as mRNA and miRNA, acting as genetic transfer vehicles and possibly modulat-
ing gene expression of target cells [53–55]. These findings open new perspectives on the role of
GRP in chronic inflammation and calcification-related pathologies, and should also be highly
relevant to our current molecular knowledge on intercellular communication involved in
physiological and pathological processes, warranting further investigation.
It should be noted that although THP-1 immortalized cell line might not entirely reflect the
biological function of monocytes/macrophages, our previously published studies showing the
anti-inflammatory potential of GRP in articular cells [16], its anti-mineralization function,
and its presence in immune cells associated to different pathologies [16, 31], strongly support
the findings and conclusions presented in this work. Nevertheless, the anti-inflammatory func-
tion of GRP should be further corroborated using primary monocytes and macrophage cells,
and the association of GRP with pathological conditions such as atherosclerosis should be eval-
uated in vivo focusing on inflammatory events. Although we have focused this work on the
role of GRP in inflammatory processes, the detection of MGP in inflammatory cells and its dif-
ferential expression pattern during inflammation in THP-1 and THP-1 MoM cells, foresee a
possible involvement of MGP in inflammation that should be further addressed in the future.
Conclusions
Overall, the novel data presented here indicate a strong association of GRP and the immune
system, acting as an anti-inflammatory agent in monocyte and macrophage cells. We propose
that in a context of chronic inflammation and calcification-related pathologies, GRP might act
as a molecular mediator in the inflammation and calcification paradigm, emphasizing its
potential for future therapeutic application.
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